ArticleDiabetologia2007
C-peptide: a redundant relative of insulin?
Article in Diabetologia, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Oxidative stress and GPX2 control pancreatic vs. non-pancreatic cell fate in human endoderm.Nature communications · 2026Article
- Association between early-pregnancy serum C-peptide and risk of gestational diabetes mellitus: a nested case-control study among Chinese women.Nutrition & metabolism · 2022Article
- Biological activity versus physiological function of proinsulin C-peptide.Cellular and molecular life sciences : CMLS · 2021Article
- Microliter Sample Insulin Detection Using a Screen-Printed Electrode Modified by Nickel Hydroxide.ACS omega · 2020Article
- Novel Formulations of C-Peptide with Long-Acting Therapeutic Potential for Treatment of Diabetic Complications.Pharmaceutics · 2019Article
- C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?Molecular bioSystems · 2017Review
- An In Vitro Diagnostic for Multiple Sclerosis Based on C-peptide Binding to Erythrocytes.EBioMedicine · 2016Article
- Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.Diabetology & metabolic syndrome · 2009Article
- Growth factor control of pancreatic islet regeneration and function.Pediatric diabetes · 2009Review
- C-Peptide and its intracellular signaling.The review of diabetic studies : RDS · 2009Article
- Intracellular signalling by C-peptide.Experimental diabetes research · 2008Review
- Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter.Diabetologia · 2008Article
- Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology.Journal of molecular medicine (Berlin, Germany) · 2007Review
- C-peptide is a bioactive peptide.Diabetologia · 2007Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
17225123What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.